2,982
Views
222
CrossRef citations to date
0
Altmetric
Original

Complement deficiencies and systemic lupus erythematosus

, &
Pages 560-566 | Received 10 Mar 2007, Accepted 15 Apr 2007, Published online: 07 Jul 2009

References

  • Figueroa JE, Densen P. Infectious diseases associated with complement deficiencies. Clin Microbiol Rev 1991; 4(3)359–395
  • Jönsson G, Truedsson L, Oxelius V, Sturfelt G, Braconier JH, Sjöholm AG. Homozygous C2 deficiency in Sweden: Frequent occurrence of invasive infection, atherosclerosis and rheumatic disease. Medicine (Baltimore) 2005; 84(1)23–34
  • Ochs HD, Nonoyama S, Zhu Q, Farrington M, Wedgwood RJ. Regulation of antibody responses: The role of complement and adhesion molecules. Clin Immunol Immunopathol 1993; 67(3 Pt2)S33–S40
  • Pickering MC, Botto M, Taylor PR, Lachmann PJ, Walport MJ. Systemic lupus erythematosus, complement deficiency and apoptosis. Adv Immunol 2000; 76: 227–324
  • Rugonfalvi-Kiss S, Endresz V, Madsen HO, Burian K, Duba J, Prohaszka Z, et al. Association of Chlamydia pneumoniae with coronary artery disease and its progression is dependent on the modifying effect of mannose-binding lectin. Circulation 2002; 106(9)1071–1076
  • Brown EJ, Hosea SW, Frank MM. The role of antibody and complement in the reticuloendothelial clearance of pneumococci from the bloodstream. Rev Infect Dis 1983; 5(Suppl 4)S797–S805
  • Brown JS, Hussell T, Gilliland SM, Holden DW, Paton JC, Ehrenstein MR, et al. The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice. Proc Natl Acad Sci (USA) 2002; 99(26)16969–16974
  • Buono C, Come CE, Witztum JL, Maguire GF, Connelly PW, Carroll M, et al. Influence of C3 deficiency on atherosclerosis. Circulation 2002; 105(25)3025–3031
  • Mitchell DA, Pickering MC, Warren J, Fossati-Jimack L, Cortes-Hernandez J, Cook HT, et al. C1q deficiency and autoimmunity: The effects of genetic background on disease expression. J Immunol 2002; 168(5)2538–2543
  • Carroll MC. A protective role for innate immunity in systemic lupus erythematosus. Nat Rev Immunol 2004; 4(10)825–831
  • Walport MJ. Complement. First of two parts. NJEM 2001; 344(14)1058–1066
  • Hourcade DE. The role of properdin in the assembly of the alternative pathway C3 convertases of complement. J Biol Chem 2006; 281(4)2128–2132
  • Pillemer L. The properdin system. Trans NY Acad Sci 1955; 17(7)526–530
  • Medzhitov R, Janeway C, Jr. Innate immunity. NJEM 2000; 343(5)338–344
  • Sjöholm AG, Jönsson G, Braconier JH, Sturfelt G, Truedsson L. Complement deficiency and disease: An update. Mol Immunol 2006; 43(1–2)78–85
  • Fijen CA, van den Bogaard R, Schipper M, Mannens M, Schlesinger M, Nordin FG, et al. Properdin deficiency: Molecular basis and disease association. Mol Immunol 1999; 36(13–14)863–867
  • Zipfel PF, Heinen S, Jozsi M, Skerka C. Complement and diseases: Defective alternative pathway control results in kidney and eye diseases. Mol Immunol 2006; 43(1–2)97–106
  • Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C, et al. Complement factor H polymorphism in age-related macular degeneration. Science 2005; 308(5720)385–389
  • Manderson AP, Botto M, Walport MJ. The role of complement in the development of systemic lupus erythematosus. Annu Rev Immunol 2004; 22: 431–456
  • Jonsen A, Gunnarsson I, Gullstrand B, Svenungsson E, Bengtsson AA, Nived O, et al. Association between SLE nephritis and polymorphic variants of the CRP and FcgammaRIIIa genes. Rheumatology 2007, in press.
  • Lipsker DM, Schreckenberg-Gilliot C, Uring-Lambert B, Meyer A, Hartmann D, Grosshans EM, et al. Lupus erythematosus associated with genetically determined deficiency of the second component of the complement. Arch Dermatol 2000; 136(12)1508–1514
  • Yang Y, Chung EK, Zhou B, Lhotta K, Hebert LA, Birmingham DJ, et al. The intricate role of complement component C4 in human systemic lupus erythematosus. Curr Dir Autoimmun 2004; 7: 98–132
  • Truedsson L, Sturfelt G, Johansen P, Nived O, Thuresson B. Sharing of MHC haplotypes among patients with systemic lupus erythematosus from unrelated Caucasian multicase families: Disease association with the extended haplotype [HLA, B8, SC01, DR17]. J Rheumatol 1995; 22(10)1852–1861
  • Jönsen A, Bengtsson AA, Sturfelt G, Truedsson L. Analysis of HLA DR, HLA DQ, C4A, FcgammaRIIa, Fcgamma RIIIA, MBL and IL-1Ra allelic variants in Caucasian systemic lupus erythematosus patients suggests an effect of combined Fcgamma RIIa R/R andIL-1Ra 2/2 genotypes on disease susceptibility. Arthritis Res Ther 2004; 6(6)R557–R562
  • Jönsson G, Sjöholm AG, Truedsson L, Bengtsson AA, Braconier JH, Sturfelt G. Rheumatological manifestations, organ damage and autoimmunity in hereditary C2 deficiency Rheumatology 2007;46(7):1133–1139.
  • Maddison PJ, ANA-negative SLE. Clin Rheum Dis 1982; 8(1)105–119
  • Jönsen A, Gullstrand B, Güner N, Bengtsson AA, Nived O, Truedsson L, et al. Genetically determined mannan-binding lectin deficiency is of minor importance in determining susceptibility to severe infections and vascular organ damage in systemic lupus erythematosus. Lupus 2007; 16(3)1–9
  • Garred P, Madsen HO, Halberg P, Petersen J, Kronborg G, Svejgaard A, et al. Mannose-binding lectin polymorphisms and susceptibility to infection in systemic lupus erythematosus. Artritis Rheum 1999; 42(10)2145–2152
  • Garred P, Pressler T, Madsen HO, Frederiksen B, Svejgaard A, Hoiby N, et al. Association between mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis. J Clin Invest 1999; 104(4)431–437
  • Carlsson M, Sjöholm AG, Eriksson L, Thiel S, Jensenius JC, Segelmark M, et al. Deficiency of the mannan-binding lectin pathway of complement and poor outcome in cyctic fibrosis: Bacterial colonization may be decisive for a relationship. Clin Exp Immunol 2005; 139(2)306–313
  • Troelsen LN, Garred P, Madsen HO, Jacobsen S. Genetically determined high serum levels of mannose-binding lectin and agalactosyl IgG are associated with ischemic heart disease in rheumatoid arthritis. Arthritis Rheum 2007; 56(1)21–29
  • Best LG, Davidson M, North KE, MacCluer JW, Zhang Y, Lee ET, et al. Prospective analysis of mannose-binding lectin genotypes and coronary artery disease in American Indians: The strong heart study. Circulation 2004; 109(4)471–475
  • Madsen HO, Videm V, Svejgaard A, Svennevig JL, Garred P. Association of mannose-binding lectin deficiency with severe atherosclerosis. Lancet 1998; 352(9132)959–960
  • Ohlenschlaeger T, Garred P, Madsen HO, Jacobsen S. Mannose-binding lectin variant alleles and the risk of arterial thrombosis in systemic lupus erythematosus. N Engl J Med 2004; 351(3)260–267
  • Tsutsumi A, Takahashi R, Sumida T. Mannose binding lectin: Genetics and autoimmune disease. Autoimmun Rev 2005; 4(6)364–372
  • Sturfelt G, Truedsson L. Complement and its breakdown products in SLE. Rheumatology (Oxford) 2005; 44(10)1227–1232
  • Davies KA, Peters AM, Beynon HL, Walport MJ. Immune complex processing in patients with systemic lupus erythematosus in vivo imaging and clearance studies. J Clin Invest 1992; 90(5)2075–2083
  • Iida K, Mornaghi R, Nussenzweig V. Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus. J Exp Med 1982; 155(5)1427–1438
  • Walport MJ, Ross GD, Mackworth-Young C, Watson JV, Hogg N, Lachmann PJ. Family studies of erythrocyte complement receptor type 1 levels: Reduced levels in patients with SLE are acquired, not inherited. Clin Exp Immunol 1985; 59(3)547–554
  • Botto M. C1q knock-out mice for the study of complement deficiency in autoimmune disease. Exp Clin Immunogenet 1998; 15(4)231–234
  • Botto M, Walport MJ. C1q, autoimmunity and apoptosis. Immunobiology 2002; 205(4–5)395–406
  • Taylor PR, Carugati A, Fadok VA, Cook HT, Andrews M, Carroll MC, et al. Hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. J Exp Med 2000; 192(3)359–366
  • Carroll MC. The role of complement in B-cell activation and tolerance. Adv Immunol 2000; 74: 61–88
  • Yamada M, Oritani K, Kaisho T, Ishikawa J, Yoshida H, Takahashi I, et al. Complement C1q regulates LPD-induced cytokine production in bone marrow derived dendritic cells. Eur J Immunol 2004; 34(1)221–230
  • Rönnblom L, Eloranta ML, Alm GV. Role of natural interferon-alpha producing cells (plasmacytoid dendritic cells) in autoimmunity. Autoimmunity 2003; 36(8)463–472
  • Pascual V, Farkas L, Banchereau J. Systemic lupus erythematosus: All roads lead to type I interferons. Curr Opin Immunol 2006; 18(6)676–682
  • Trouw LA, Roos A, Daha MR. Autoantibodies to complement components. Mol Immunol 2001; 38(2–3)199–206
  • Trendelenburg M. Antibodies against C1q in patients with systemic lupus erythematosus. Springer Semin Immunopathol 2005; 27(3)276–285
  • Tsacheva I, Radanova M, Todorova N, Argirova T, Kishore U. Detection of autoantibodies against the globular domain of human C1q in the sera of systemic lupus erythematosus patients. Mol Immunol 2007; 44(8)2157–2161
  • Steinsson K, Erlendsson K, Valdimarsson H. Successful plasma infusion treatment of a patient with C2 deficiency and systemic lupus erythematosus: Clinical experience over forty-five months. Arthritis Rheum 1989; 32(7)906–913
  • Sibilia J. Treatment of systemic lupus erythematosus in 2006. Joint Bone Spine 2006; 73(6)591–598

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.